Nature Communications (Dec 2021)

Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ)

  • Oksana Degtjarik,
  • Dmitrij Golovenko,
  • Yael Diskin-Posner,
  • Lars Abrahmsén,
  • Haim Rozenberg,
  • Zippora Shakked

DOI
https://doi.org/10.1038/s41467-021-27142-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 17

Abstract

Read online

The tumor suppressor p53 is mutated in more than half of human cancers and the compound methylene quinuclidinone (MQ) was shown to reactivate p53 mutants by binding covalently to cysteine residues. Here, the authors present crystal structures of wild-type and cancer related p53 mutant core domains bound to MQ alone and in complex with their DNA response elements and observe that MQ is bound to several cysteine residues located at the surface of the core domain.